NCT00136201View on ClinicalTrials.gov

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Abdominal Abscess

Interventions

DRUG

tigecycline

Trial Locations (11)

100044

Beijing

100730

Beijing

100853

Beijing

110001

Shengyang

200001

Shanghai

200040

Shanghai

200092

Shanghai

200433

Shanghai

300063

Wuhan

610041

Guoxuexiang

Unknown

Hangzhou

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00136201 - Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections | Biotech Hunter | Biotech Hunter